Skip to main content

Robert E. Beasley, MD, FSCAI, FSIR

UltraScore Study Results
First-Time Data Release/LINC 2022
06/07/2022
Dr. Robert Beasley discusses the results of a 12-month study of the clinical use of the UltraScore balloon in a real-world, on-label, clinical application.
Dr. Robert Beasley discusses the results of a 12-month study of the clinical use of the UltraScore balloon in a real-world, on-label, clinical application.
Dr. Robert Beasley discusses the...
06/07/2022
Vascular Disease Management
Original Contribution
04/25/2017
Non-invasive limb hemodynamics may aid in diagnosis of CLI, although the relationship with disease severity and response to endovascular therapy is unclear. This prospective, single-center study enrolled 100 CLI patients who underwent...
Non-invasive limb hemodynamics may aid in diagnosis of CLI, although the relationship with disease severity and response to endovascular therapy is unclear. This prospective, single-center study enrolled 100 CLI patients who underwent...
Non-invasive limb hemodynamics...
04/25/2017
Journal of Invasive Cardiology
Dr Beasley
ISET 2023
01/17/2023
At Tuesday's ISET 2023 sessions, Dr. Robert Beasley presented 3-year results of MIMICS, a prospective, multicenter, observational study that evaluated BioMimics 3D in 507 patients with peripheral arterial disease at 23 investigational sites...
At Tuesday's ISET 2023 sessions, Dr. Robert Beasley presented 3-year results of MIMICS, a prospective, multicenter, observational study that evaluated BioMimics 3D in 507 patients with peripheral arterial disease at 23 investigational sites...
At Tuesday's ISET 2023 sessions,...
01/17/2023
Vascular Disease Management
Original Contribution
05/27/2016
Journal of Invasive Cardiology
Case Study
08/02/2018
The Mount Sinai Medical Center featured the first in-man MicroStent and has thus far completed 5 total cases, all with procedural success and no complications in up to 30-day follow-up.
The Mount Sinai Medical Center featured the first in-man MicroStent and has thus far completed 5 total cases, all with procedural success and no complications in up to 30-day follow-up.
The Mount Sinai Medical Center...
08/02/2018
Cath Lab Digest
FDA Panel
06/28/2019
VDM talks with Robert E. Beasley, MD, FSIR, FSCAI, Director, Vascular/Interventional Radiology Lab and Evanescence Vein Center, Mount Sinai Medical Center, Miami Beach, Florida.
VDM talks with Robert E. Beasley, MD, FSIR, FSCAI, Director, Vascular/Interventional Radiology Lab and Evanescence Vein Center, Mount Sinai Medical Center, Miami Beach, Florida.
VDM talks with Robert E....
06/28/2019
Vascular Disease Management
Cutting-Edge Perspectives
09/16/2019
Robert Beasley, MD, talks with Nicolas W. Shammas, MD, MS, Midwest Cardiovascular Research Foundation, Davenport, Iowa.
Robert Beasley, MD, talks with Nicolas W. Shammas, MD, MS, Midwest Cardiovascular Research Foundation, Davenport, Iowa.
Robert Beasley, MD, talks with...
09/16/2019
Vascular Disease Management
Commentary
01/14/2020
Michael Patel, MD, and Robert Beasley, MD discuss drug-eluting stents and drug-coated balloons.
Michael Patel, MD, and Robert Beasley, MD discuss drug-eluting stents and drug-coated balloons.
Michael Patel, MD, and Robert...
01/14/2020
Vascular Disease Management
Case Study
08/02/2018
The Mount Sinai Medical Center featured the first in-man MicroStent and has thus far completed 5 total cases, all with procedural success and no complications in up to 30-day follow-up.
The Mount Sinai Medical Center featured the first in-man MicroStent and has thus far completed 5 total cases, all with procedural success and no complications in up to 30-day follow-up.
The Mount Sinai Medical Center...
08/02/2018
Cath Lab Digest